◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocksCVS › Revenue

CVS Health Corp (CVS) Revenue 2006–TTM

DATA UPDATED 2026-07-12

CVS Health Corp annual revenue for fiscal TTM was $407.9 billion, an increase of 1.5% from $402.1 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

CVS Annual Revenue

Revenue (annual)TTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$407.9B$402.1B$372.8B$357.8B$322.5B$292.1B$268.7B$256.8B$194.6B$184.8B$177.5B$153.3B$139.4B$126.8B$123.1B$107.1B$95.8B$98.2B$87.5B$76.3B$43.8B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CVS Quarterly Revenue

Revenue (quarterly)2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$100.4B$105.7B$102.9B$98.9B$94.6B$97.7B$95.4B$91.2B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More CVS metrics: Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All CVS financial statements → Interactive CVS charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.